MGT Capital Investments, Inc.: Failure to Satisfy a Continued Listing Rule Based on a Lack of Shareholder Meeting in 2008 and Me
February 12 2009 - 4:36PM
PR Newswire (US)
NEW YORK, Feb. 12 /PRNewswire-FirstCall/ -- MGT Capital
Investments, Inc. (NYSE Alternext US: MGT) - Tim Paterson-Brown,
Chairman and CEO of MGT, stated, "The Company has been considering
various strategic alternatives which would require shareholder
approval, and we therefore delayed holding our 2008 annual general
meeting. On February 10, 2009, we received notice from the staff of
the NYSE Alternext US LLC (the "Exchange") that the Company does
not meet one of the Exchange's continued listing standards because
it failed to hold an annual meeting of its shareholders in 2008 as
required in Section 704 of the Exchange's Company Guide. "The
Company is aware of its obligations under the Company Guide, and
plans to hold an annual general meeting before June 30, 2009. The
Company has been afforded the opportunity to submit a plan of
compliance to the Exchange by March 10, 2009 to demonstrate the
ability to regain compliance with this requirement by August 10,
2009. The Company fully intends to do this. If the Company does not
submit such a plan or if the plan is not accepted by the Exchange,
the Company will be subject to delisting procedures as set forth in
Section 1010 and part 12 of the Company Guide." Medicsight PLC
(AIM: MDST) is a subsidiary of the Company, and an industry leader
in the development of Computer-Aided Detection (CAD) and image
analysis software which assists radiologists in the early detection
of disease, comments on the recently published CMS (Center for
Medicare and Medicaid Services) report that concluded that evidence
is inadequate to show that CT colonography is an appropriate
colorectal screening test, and, as such, the procedure is not
reimbursable. The CMS has requested public comments on this
proposed determination pursuant to Section 1862(1) of the Social
Security Act. After considering the public comments, it will make a
final determination and issue a final decision memorandum.
Medicsight is in discussions with its strategic partners and
clinical advisors to assess the implication this may have on the
Company. Reimbursement is, however, available for diagnostic
procedures. The area wherein the CMS proposed decision may impact
is in colorectal screening only. David Sumner, Chief Executive of
Medicsight, said: "We look forward to the feedback from public
comment and hope the decision returns as a positive for
Medicsight." About MGT Capital Investments, Inc. MGT Capital
Investments, Inc. is a technology holding company that focuses on
investments in the global healthcare information technology market.
The Company has two subsidiaries, Medicsight PLC and Medicexchange
PLC. Medicsight PLC (AIM: MDST) is a UK-headquartered, research
driven, leading developer of computer-aided detection (CAD) and
image analysis software for the medical imaging market. The CAD
software automatically highlights suspicious areas on computerized
tomography (CT) scans of the colon and lung, helping radiologists
to identify, measure and analyze potential disease and early
indicators of disease. Medicsight's CAD software has been validated
using one of the world's largest and most population diverse
databases of verified patient CT scan data. Medicsight's
ColonCAD(TM) and LungCAD(TM) software products are seamlessly
integrated with the advanced 3D visualization workstations of
several industry-leading imaging equipment partners. Medicexchange
PLC provides medical imaging professionals with a global web portal
containing an online sales, jobs and information channel for
diagnostic, treatment and surgery planning solutions. This combined
with a variety of relevant clinical papers, training materials and
content gives these professionals access to information and
products that they otherwise would have difficulty accessing.
Additional information can be found at http://www.mgtci.com/. All
forward-looking statements are made pursuant to the 'safe harbor'
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are based on current management
expectations that involve risks and uncertainties that may result
in such expectations not being realized. Potential risks and
uncertainties include, but are not limited to, the risks described
in company filings with the Securities and Exchange Commission.
Investor & Media enquiries: KCSA Strategic Communications Todd
Fromer / Garth Russell Tel: +1 212-896-1215 / 212-896-1250 /
DATASOURCE: MGT Capital Investments, Inc. CONTACT: Todd Fromer,
+1-212-896-1215, , or Garth Russell, +1-212-896-1250, , both of
KCSA Strategic Communications for MGT Capital Investments, Inc. Web
Site: http://www.mgtci.com/
Copyright